These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 23902823)

  • 21. The need for standardization of tacrolimus assays.
    Levine DM; Maine GT; Armbruster DA; Mussell C; Buchholz C; O'Connor G; Tuck V; Johnston A; Holt DW
    Clin Chem; 2011 Dec; 57(12):1739-47. PubMed ID: 21998339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An isotope dilution LC-MS/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood.
    Taibon J; van Rooij M; Schmid R; Singh N; Albrecht E; Anne Wright J; Geletneky C; Schuster C; Mörlein S; Vogeser M; Seger C; Pongratz S; Kobold U
    Clin Biochem; 2020 Aug; 82():73-84. PubMed ID: 31770523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Waters MassTrak LC-MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay.
    Saitman A; Metushi IG; Mason DS; Fitzgerald RL
    Ther Drug Monit; 2016 Jun; 38(3):300-4. PubMed ID: 26473523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods.
    De BK; Jimenez E; De S; Sawyer JC; McMillin GA
    Clin Chim Acta; 2009 Dec; 410(1-2):25-30. PubMed ID: 19751714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic drug monitoring of immunosuppressants by liquid chromatography-mass spectrometry.
    McShane AJ; Bunch DR; Wang S
    Clin Chim Acta; 2016 Feb; 454():1-5. PubMed ID: 26721314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs.
    Zhang Y; Zhang R
    Drug Test Anal; 2018 Jan; 10(1):81-94. PubMed ID: 28851030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.
    Taylor PJ; Tai CH; Franklin ME; Pillans PI
    Clin Biochem; 2011 Jan; 44(1):14-20. PubMed ID: 20599871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Some thoughts on the links between LC-MS/MS and therapeutic drug monitoring].
    Saint-Marcoux F
    Ann Biol Clin (Paris); 2015; 73(1):49-53. PubMed ID: 25582722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.
    Seger C
    Wien Med Wochenschr; 2012 Nov; 162(21-22):499-504. PubMed ID: 23129542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry.
    Bronsema KJ; Bischoff R; van de Merbel NC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():1-14. PubMed ID: 22426285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
    Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
    Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harmonization of Liquid Chromatography-Tandem Mass Spectrometry Protein Assays.
    Rockwood AL; Lowenthal MS; Bystrom C
    Clin Lab Med; 2018 Sep; 38(3):499-513. PubMed ID: 30115394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring.
    Jusko WJ
    Ther Drug Monit; 1995 Dec; 17(6):596-601. PubMed ID: 8588227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. After another decade: LC-MS/MS became routine in clinical diagnostics.
    Seger C; Salzmann L
    Clin Biochem; 2020 Aug; 82():2-11. PubMed ID: 32188572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus document: therapeutic monitoring of tacrolimus (FK-506).
    Jusko WJ; Thomson AW; Fung J; McMaster P; Wong SH; Zylber-Katz E; Christians U; Winkler M; Fitzsimmons WE; Lieberman R
    Ther Drug Monit; 1995 Dec; 17(6):606-14. PubMed ID: 8588229
    [No Abstract]   [Full Text] [Related]  

  • 37. Standardization of LC-MS for therapeutic drug monitoring of tacrolimus.
    Annesley TM; McKeown DA; Holt DW; Mussell C; Champarnaud E; Harter L; Calton LJ; Mason DS
    Clin Chem; 2013 Nov; 59(11):1630-7. PubMed ID: 23902823
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.